Candriam SCA’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68M | Hold |
246,030
| – | – | 0.02% | 400 |
|
|
2025
Q1 | $3.97M | Sell |
246,030
-1,561
| -0.6% | -$25.2K | 0.02% | 378 |
|
|
2024
Q4 | $5.76M | Buy |
247,591
+142,591
| +136% | +$3.32M | 0.03% | 335 |
|
|
2024
Q3 | $3.09M | Hold |
105,000
| – | – | 0.02% | 435 |
|
|
2024
Q2 | $2.47M | Hold |
105,000
| – | – | 0.02% | 453 |
|
|
2024
Q1 | $3.98M | Buy |
+105,000
| New | +$3.98M | 0.03% | 383 |
|